Site-specific cancer risk in patients with type 2 diabetes: a nationwide population-based cohort study in Korea
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Background/Aims: We aimed to evaluate site-specific cancer risk in diabetic patients and to investigate causal and temporal relationships by analyzing organ- specific cancer risk according to the duration of diabetes. Methods: Using a database provided by the Korean National Health Insurance Service, we conducted a retrospective, population-based cohort study of adults aged ≥ 30 years from January 2005 to December 2013. To verify the possibility of detection bias or reverse causation, we compared hazard ratios (HRs) for each cancer according to the following duration of diabetes: less than 6 months, 6 months to 3 years, and more than 3 years. Results: The incidence of overall cancer per 1,000 person-years was higher in patients with diabetes than in those without diabetes (20.36 vs. 10.83). The overall cancer risk according to the duration of diabetes was the highest within the first 6 months after diagnosis (HR, 2.03; 95% confidence interval [CI], 1.99 to 2.07), and the HR decreased with the duration of diabetes, ranging from 1.19 (95% CI, 1.18 to 1.21) between 6 months and 3 years to 1.12 (95% CI, 1.11 to 1.13) after 3 years. Both overall cancer risk and HR remained significantly higher in patients with diabetes than in those without diabetes. The risk for prostate cancer was higher in men with diabetes than in those without diabetes (HR, 1.12; 95% CI, 1.10 to 1.14). In women, the risk for endometrial cancer was significantly higher in patients with diabetes than in those without diabetes throughout the duration of diabetes. Conclusions: The risk for stomach, colorectum, liver, pancreas, and kidney cancer appeared to be higher in patients with diabetes than in those without diabetes regardless of the sex or duration of diabetes.
Abstract
Background/Aims: We aimed to evaluate site-specific cancer risk in diabetic patients and to investigate causal and temporal relationships by analyzing organ- specific cancer risk according to the duration of diabetes. Methods: Using a database provided by the Korean National Health Insurance Service, we conducted a retrospective, population-based cohort study of adults aged ≥ 30 years from January 2005 to December 2013. To verify the possibility of detection bias or reverse causation, we compared hazard ratios (HRs) for each cancer according to the following duration of diabetes: less than 6 months, 6 months to 3 years, and more than 3 years. Results: The incidence of overall cancer per 1,000 person-years was higher in patients with diabetes than in those without diabetes (20.36 vs. 10.83). The overall cancer risk according to the duration of diabetes was the highest within the first 6 months after diagnosis (HR, 2.03; 95% confidence interval [CI], 1.99 to 2.07), and the HR decreased with the duration of diabetes, ranging from 1.19 (95% CI, 1.18 to 1.21) between 6 months and 3 years to 1.12 (95% CI, 1.11 to 1.13) after 3 years. Both overall cancer risk and HR remained significantly higher in patients with diabetes than in those without diabetes. The risk for prostate cancer was higher in men with diabetes than in those without diabetes (HR, 1.12; 95% CI, 1.10 to 1.14). In women, the risk for endometrial cancer was significantly higher in patients with diabetes than in those without diabetes throughout the duration of diabetes. Conclusions: The risk for stomach, colorectum, liver, pancreas, and kidney cancer appeared to be higher in patients with diabetes than in those without diabetes regardless of the sex or duration of diabetes.
참고문헌 (32)
- International Diabetes Federation, "IDF Diabetes Atlas" (2015), International Diabetes Federation
- Li J, "Differences between Western and Asian type 2 diabetes patients in the incidence of vascular complications and mortality : a systematic review of randomized controlled trials on lowering blood glucose", J Diabetes, 8, pp.824~833 (2016)
- Andersen GS, "Diabetes among migrants in Denmark : incidence, mortality, and prevalence based on a longitudinal register study of the entire Danish population", Diabetes Res Clin Pract, 122, pp.9~16 (2016)
- Papier K, "Incidence and risk factors for type 2 diabetes mellitus in transitional Thailand : results from the Thai cohort study", BMJ Open, 6, pp.e014102~ (2016)
- 하경화, "Trends in the Diabetes Epidemic in Korea", Endocrinology and Metabolism, 30(2), pp.142~146 (2015), 대한내분비학회
- "Korean Diabetes Fact Sheet 2015" (2015)[URL]
- Magliano DJ, "Incidence and predictors of all-cause and site-specific cancer in type 2 diabetes : the Fremantle Diabetes Study", Eur J Endocrinol, 167, pp.589~599 (2012)
- Oberaigner W, "Increased cancer incidence risk in type 2 diabetes mellitus : results from a cohort study in Tyrol", Austria, 2014, pp.14, 1058~
- Giovannucci E, "Diabetes and cancer : a consensus report", Diabetes Care, 33, pp.1674~1685 (2010)
- Vigneri P, "Diabetes and cancer", Endocr Relat Cancer, 16, pp.1103~1123 (2009)
- Renehan AG, "Diabetes and cancer(2) : evaluating the impact of diabetes on mortality in patients with cancer", Diabetologia, 55, pp.1619~1632 (2012)
- Szablewski L, "Diabetes mellitus : influences on cancer risk", Diabetes Metab Res Rev, 30, pp.543~553 (2014)
- Lauby-Secretan B, "Body fatness and cancer : viewpoint of the IARC working group", N Engl J Med, 375, pp.794~798 (2016)
- Font-Burgada J, "Obesity and cancer : the oil that feeds the flame", Cell Metab, 23, pp.48~62 (2016)
- Guevara-Aguirre J, "Obesity, diabetes and cancer : insight into the relationship from a cohort with growth hormone receptor deficiency", Diabetologia, 58, pp.37~42 (2015)
- Garg SK, "Diabetes and cancer : two diseases with obesity as a common risk factor", Diabetes Obes Metab, 16, pp.97~110 (2014)
- De Bruijn KM, "Detection bias may be the main cause of increased cancer incidence among diabetics : results from the Rotterdam Study", Eur J Cancer, 50, pp.2449~2455 (2014)
- Johnson JA, "Diabetes and cancer(1) : evaluating the temporal relationship between type 2 diabetes and cancer incidence", Diabetologia, 55, pp.1607~1618 (2012)
- Bansal D, "Type 2 diabetes and risk of prostate cancer : a meta-analysis of observational studies", Prostate Cancer Prostatic Dis, 16, pp.151~158 (2013)
- Pierce BL, "Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidence", Urol Oncol, 30, pp.735~743 (2012)
- Liu JH, "Genetic risk factors of prostate cancer in Han nationality population in Northern China and a preliminary study of the reason of racial difference in prevalence of prostate cancer", Zhonghua Yi Xue Za Zhi, 84, pp.364~368 (2004)
- 송선옥, "Background and Data Configuration Process of a Nationwide Population-Based Study Using the Korean National Health Insurance System", Diabetes and Metabolism Journal, 38(5), pp.395~403 (2014), 대한당뇨병학회[DOI]
- 송선옥, "Trends in Diabetes Incidence in the Last Decade Based on Korean National Health Insurance Claims Data", Endocrinology and Metabolism, 31(2), pp.292~299 (2016), 대한내분비학회
- 이용호, "Data Analytic Process of a Nationwide Population-Based Study Using National Health Information Database Established by National Health Insurance Service", Diabetes and Metabolism Journal, 40(1), pp.79~82 (2016), 대한당뇨병학회[DOI]
- 서성환, "Diabetes and Cancer: Is Diabetes Causally Related to Cancer?", Diabetes and Metabolism Journal, 35(3), pp.193~198 (2011), 대한당뇨병학회
- Lega IC, "The temporal relationship between diabetes and cancer : a population-based study", Cancer, 122, pp.2731~2738 (2016)
- Nath SD, "Fasting serum glucose level and cancer risk in Korean men and women", JAMA, 293, pp.2210~2211 (2005)
- Crawley D, "A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus", Ecancermedicalscience, 12, pp.802~ (2018)
- 전자영, "Current Status of Glycemic Control of Patients with Diabetes in Korea: The Fifth Korea National Health and Nutrition Examination Survey", Diabetes and Metabolism Journal, 38(3), pp.197~203 (2014), 대한당뇨병학회[DOI]
- Ko SH, "Trends of antidiabetic drug use in adult type 2 diabetes in Korea in 2002-2013:nationwide population-based cohort study", Medicine (Baltimore), 95, pp.e4018~ (2016)
- Pearson-Stuttard J, "Worldwide burden of cancer attributable to diabetes and high body-mass index : a comparative risk assessment", Lancet Diabetes Endocrinol, 6, pp.95~104 (2018)
- 구보경, "Are We in the Same Risk of Diabetes Mellitus? Genderand Age-Specific Epidemiology of Diabetes in 2001 to 2014 in the Korean Population", Diabetes and Metabolism Journal, 40(3), pp.175~181 (2016), 대한당뇨병학회[DOI]